Veidlapa Nr. M-3 (8)
Study Course Description
Adult Haematology
Course Code
RBH_017
Branch of Science
Clinical medicine
ECTS
6.00
Target Audience
Medicine
LQF
Level 8
Study Course Implementer
Course Supervisor
Žanna Kovaļova
Residency Speciality
Speciality
Pediatric oncohematologist
Supervisor of Medical Speciality
Žanna Kovaļova
Contacts
-
About Study Course
Objective
Assure theoretical knowledge and practical skills acquisition in the field of adult haematology.
Learning Outcomes
Knowledge
1.Use in dayly practice knowledge about classification and treatment principles of adult lymphomas, of treatment of myelomatous diseases, DIC-syndrome etiology, pathogenesis, treatment. Use diagnostic methods, differentiate haematological disease of adults. Explain differencies between adult and children's haematological diseases, Analyse results of diagnostic examinations (bone marrow cytology, complete blood counts).
Skills
1.Communicate with colleagues, patients and their relatives, even in critical and psychically traumatic situations.
Competences
1.To be competent of similarities and differences between paediatric haematology and oncology and adult haematology.
Assessment
Individual work
|
Title
|
% from total grade
|
Grade
|
|---|---|---|
|
1.
Individual work |
-
|
-
|
|
Prepare a presentation on the corresponding seminar topic.
|
||
Examination
|
Title
|
% from total grade
|
Grade
|
|---|---|---|
|
1.
Examination |
-
|
-
|
|
After each module (rotation cycle) medical resident’s theoretical and practical knowledge is assessed in a 10-point grade system by the medical resident's supervisor of the rotation cycle by making a respective record in the medical resident’s book.
|
||
Study Course Theme Plan
FULL-TIME
Part 1
-
Seminar
|
Modality
|
Location
|
|
|---|---|---|
|
On site
|
Auditorium
|
Topics
|
Lymphoma. Diagnostics, treatment principles.
|
-
Seminar
|
Modality
|
Location
|
|
|---|---|---|
|
On site
|
Auditorium
|
Topics
|
Myeloma disease.
|
-
Seminar
|
Modality
|
Location
|
|
|---|---|---|
|
On site
|
Auditorium
|
Topics
|
DIC syndrome, congenital coagulopathies, thrombophilia.
|
Total ECTS (Creditpoints):
6.00
Number of Residency Seminars:
3
Length (weeks):
4
Final Examination:
Residency exam (Theory and practice)
Bibliography
Required Reading
1.
Klīniskā hematoloģija. S.Lejniece. Rīga, 2020, 440 lpp.
2.
Heuser, Y. Ofran, N. Boissel, S. Brunet Mauri, et.al. on behalf of the ESMO Guidelines Committee. Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upy. Published in 2020 – Ann Oncol (2020); 31(0): 697-712.
3.
NCCN Clinical Practice Guidelines in Oncology. Myelodisplastic syndromes. Version 1.2020.- August27, 2019.
4.
Guillermo Montalban-Bravo, Guillermo Garcia-Manero.M yelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management. Am J Hematol. 2018;93:129–147.
5.
P. Fenaux, D. Haase, G. F. Sanz, V. Santini, C. Buske on behalf of the ESMO Guidelines Working Group. Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 25 (Supplement 3): iii57–iii69, 2014 doi:10.1093/annonc/mdu180
6.
Greenberg P.L., Tuechler H., Schanz J., et.al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–2465. doi:10.1182/blood-2012-03-420489
7.
Arber D.A., Orazi A., Hasserjian R., et.al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127:2391-2405.
8.
Emile J.F., Abla O., Fraitag S., et.al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016; 127:2672.